Pe. Andreotti et al., TCA-100 TUMOR CHEMOSENSITIVITY ASSAY - DIFFERENCES IN SENSITIVITY BETWEEN CULTURED TUMOR-CELL LINES AND CLINICAL-STUDIES, Journal of bioluminescence and chemiluminescence, 9(6), 1994, pp. 373-378
The BATLE LE TCA-100 tumour chemosensitivity assay has been used to ev
aluate chemotherapeutic drug sensitivity of cultured tumour cell lines
. Studies were performed using test drug concentrations calibrated to
discriminate sensitivity and resistance of clinical specimens. Strong
sensitivity which appeared to be inconsistent with clinical experience
was detected for some drugs and cell lines. Findings of strong sensit
ivity were consistent with basic differences between sensitivity testi
ng cultured cell lines and clinical specimens. Results with cell lines
frequently may not apply directly to clinical applications. Character
ization of differences between cell lines and clinical specimens may a
ssist in application of cell line findings to clinical trials.